Endometriosis and malignancy: The intriguing relationship
- PMID: 33415752
- DOI: 10.1002/ijgo.13585
Endometriosis and malignancy: The intriguing relationship
Abstract
Objective: To determine the prevalence and study the association of ovarian, uterine, and breast cancers with endometriosis.
Methods: A cross-sectional study of all women with a tissue-proven diagnosis of endometriosis postoperatively in a tertiary care hospital between January 1, 2010, and December 31, 2019, was conducted to determine the prevalence of coexistent malignancy. Patient details were obtained from electronic clinical records. Univariate analysis followed by multivariate analysis was done to find independent risk factors associated with malignancy.
Results: Out of 800 patients, 104 (13.0%) were found to have coexistent malignancy: ovarian (50, 6.2%); endometrial (33, 4.1%); synchronous ovarian and endometrial (7, 0.9%); and breast (14, 1.8%). Increasing age (odds ratio [OR] 1.13; 95% confidence interval [CI] 1.09-1.16), higher levels of cancer antigen 125 (CA 125) (OR 1.002; 95% CI 1.001-1.005), postmenopausal status (OR 6.2; 95% CI 2.0-19.2), duration of endometriosis over 5 years (OR 4.7; 95% CI 2.5-9.0), and endometriomas larger than 8 cm (area under the curve 0.83) were predictive of coexistent malignancy.
Conclusion: Endometriosis is associated with an increased risk of ovarian, endometrial, and breast malignancy. Increasing age, postmenopausal status, higher levels of CA 125, larger endometrioma, and long-standing disease are predictive risk factors.
Keywords: breast cancer; endometrial cancer; endometriosis; ovarian cancer.
© 2021 International Federation of Gynecology and Obstetrics.
Comment in
-
Letter to the Editor: Endometriosis and malignancy-The intriguing relationship.Int J Gynaecol Obstet. 2021 Jun;153(3):556-557. doi: 10.1002/ijgo.13687. Epub 2021 Apr 9. Int J Gynaecol Obstet. 2021. PMID: 33837546 No abstract available.
-
Response: Endometriosis and malignancy-The intriguing relationship.Int J Gynaecol Obstet. 2021 Jun;153(3):558-559. doi: 10.1002/ijgo.13688. Epub 2021 Apr 13. Int J Gynaecol Obstet. 2021. PMID: 33848009 No abstract available.
References
REFERENCES
-
- Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C, Nezhat C. The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril. 2008;90(5):1559-1570.
-
- Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997;176(3):572-579.
-
- Krawczyk N, Banys-Paluchowski M, Schmidt D, Ulrich U, Fehm T. Endometriosis-associated malignancy. Geburtshilfe Frauenheilkd. 2016;76(2):176-181.
-
- Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-275.
-
- Mogensen JB, Kjaer SK, Mellemkjaer L, Jensen A. Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol. 2016;143(1):87-92.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials